Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.2K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.2K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Combination therapy in sarcomas and the challenges of heterogeneity.

Chinese clinical oncology·2026
Same author

Genomic Landscape of Myoepithelial Carcinoma Tumors.

Oral diseases·2026
Same author

A Comprehensive Review of Chemotherapy in Localized Soft Tissue Sarcomas: Is the Cat Out of the Bag Yet?

Indian journal of surgical oncology·2025
Same author

High-throughput screening identifies the activity of histone deacetylase inhibitors in patient-derived models of soft tissue sarcoma.

Cancer biology & therapy·2025
Same author

Health-related quality of life in patients with advanced soft tissue sarcoma receiving first-line palliative chemotherapy (HOLISTIC): longitudinal results from a prospective, observational cohort study.

EClinicalMedicine·2025
Same author

Guidelines for Next-Generation Sequencing in Sarcoma Diagnosis and Treatment: A Consensus Review.

JAMA oncology·2025

相关实验视频

Updated: Sep 11, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

21.5K

在瘤中采用T细胞疗法

Monika Kucharczyk1, Emine Hatipoglu1, Robin L Jones1,2

  • 1The Royal Marsden NHS Foundation Trust, London, UK.

Current oncology reports
|August 14, 2025
PubMed
概括

采用T细胞疗法对瘤有希望,工程T细胞受体 (TCR-T) 准NY-ESO-1和MAGE-A4领先. 在CAR-T和TIL疗法方面的创新旨在克服瘤异质性等挑战,并改善患者的治疗结果.

关键词:
收养T细胞疗法 收养T细胞疗法癌症-丸抗原 抗原化学抗原受体T T工程T细胞受体工程T细胞受体纽约-ESO-1是什么意思肉瘤免疫疗法 免疫疗法瘤透的淋巴细胞

更多相关视频

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

15.3K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

795

相关实验视频

Last Updated: Sep 11, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

21.5K
Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

15.3K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

795

科学领域:

  • 在瘤学瘤学.
  • 免疫治疗是一种免疫疗法.
  • 细胞疗法细胞疗法

背景情况:

  • 瘤是一种异质的罕见癌症群.
  • 采用T细胞疗法代表了癌症治疗的新方法.

研究的目的:

  • 审查和评估针对肉瘤的采用T细胞疗法的最新进展.
  • 专注于治疗目标,疗效,安全性和这些治疗的局限性.

主要方法:

  • 审查当前临床试验和FDA批准的萨尔科马的采用T细胞疗法.
  • 对针对NY-ESO-1和MAGE-A4.4的T细胞受体 (TCR-T) 治疗方法的分析.
  • 对针对B7H3,GD2,FGFR4和HER2的化学抗原受体 (CAR-T) 策略的评估.
  • 对瘤浸性淋巴细胞 (TIL) 治疗与其他药物结合的评估.

主要成果:

  • 美国食品和药物管理局批准afamitresgene autoleucel和letetresgene autoleucel的突破性名称突出了TCR-T疗法的进展.
  • 卡特-T策略正在探索双抗原向和安全开关.
  • 目前正在研究使用检查点抑制剂和瘤治疗剂的TIL治疗.
  • 早期TCR-T疗法显示出有前途,但HLA限制和瘤异质性等挑战仍然存在.

结论:

  • 采用T细胞疗法,特别是TCR-T,为肉瘤治疗提供了显著的潜力.
  • 克服HLA限制,瘤异质性和制造方面的挑战至关重要.
  • 未来的方向包括新型抗原,多向和组合疗法,以扩大适用性和增强结果.